Simulations Plus (NASDAQ:SLP) Updates FY 2026 Earnings Guidance

Simulations Plus (NASDAQ:SLP) updated its FY 2026 earnings guidance on Wednesday. The company provided earnings per share guidance of 1.030-1.100 for the period, compared to the consensus earnings per share estimate of 0.870. The company issued revenue guidance of $79.0 million-$82.0 million, compared to the consensus revenue estimate of $80.0 million. Simulations Plus also updated its FY 2025 guidance to 1.030-1.030 EPS.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on SLP. Weiss Ratings reissued a “sell (d-)” rating on shares of Simulations Plus in a research report on Wednesday, October 8th. KeyCorp downgraded Simulations Plus from an “overweight” rating to a “sector weight” rating in a report on Tuesday, July 15th. Stephens dropped their price objective on Simulations Plus from $28.00 to $20.00 and set an “overweight” rating on the stock in a report on Tuesday, July 15th. Zacks Research upgraded Simulations Plus to a “hold” rating in a report on Tuesday, August 12th. Finally, TD Cowen started coverage on shares of Simulations Plus in a research note on Tuesday, September 30th. They set a “hold” rating and a $16.00 price target on the stock. Four equities research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $24.40.

Simulations Plus Stock Performance

Shares of SLP opened at $17.23 on Friday. The company has a 50-day simple moving average of $15.02 and a 200-day simple moving average of $20.58. Simulations Plus has a 52 week low of $12.39 and a 52 week high of $37.67. The firm has a market capitalization of $346.79 million, a P/E ratio of -5.47 and a beta of 0.99.

Hedge Funds Weigh In On Simulations Plus

A number of hedge funds have recently modified their holdings of the stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in shares of Simulations Plus by 4.3% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 9,493 shares of the technology company’s stock valued at $233,000 after acquiring an additional 390 shares during the period. Prudential Financial Inc. lifted its holdings in shares of Simulations Plus by 5.7% during the second quarter. Prudential Financial Inc. now owns 17,213 shares of the technology company’s stock valued at $300,000 after acquiring an additional 930 shares during the period. Invesco Ltd. boosted its position in Simulations Plus by 3.8% in the second quarter. Invesco Ltd. now owns 36,452 shares of the technology company’s stock valued at $636,000 after buying an additional 1,323 shares in the last quarter. Raymond James Financial Inc. acquired a new position in Simulations Plus in the second quarter valued at about $25,000. Finally, CANADA LIFE ASSURANCE Co boosted its position in Simulations Plus by 9.8% in the second quarter. CANADA LIFE ASSURANCE Co now owns 22,986 shares of the technology company’s stock valued at $401,000 after buying an additional 2,061 shares in the last quarter. 78.08% of the stock is owned by institutional investors and hedge funds.

Simulations Plus Company Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.